These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 37966624)
1. Nigella sativa and its chemical constituents: pre-clinical and clinical evidence for their potential anti-SARS-CoV-2 effects. Cyril AC; Ali NM; Nelliyulla Parambath A; Vazhappilly CG; Jan RK; Karuvantevida N; Aburamadan H; Lozon Y; Radhakrishnan R Inflammopharmacology; 2024 Feb; 32(1):273-285. PubMed ID: 37966624 [TBL] [Abstract][Full Text] [Related]
2. Deciphering underlying mechanism of Sars-CoV-2 infection in humans and revealing the therapeutic potential of bioactive constituents from Jakhmola Mani R; Sehgal N; Dogra N; Saxena S; Pande Katare D J Biomol Struct Dyn; 2022 Apr; 40(6):2417-2429. PubMed ID: 33111624 [TBL] [Abstract][Full Text] [Related]
3. In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity. Maiti S; Banerjee A; Kanwar M Vascul Pharmacol; 2021 Jun; 138():106856. PubMed ID: 33746069 [TBL] [Abstract][Full Text] [Related]
4. Molecular docking, simulation and MM-PBSA studies of Ahmad S; Abbasi HW; Shahid S; Gul S; Abbasi SW J Biomol Struct Dyn; 2021 Aug; 39(12):4225-4233. PubMed ID: 32462996 [No Abstract] [Full Text] [Related]
5. Koshak DAE; Koshak PEA Curr Ther Res Clin Exp; 2020; 93():100602. PubMed ID: 32863400 [TBL] [Abstract][Full Text] [Related]
6. Effects of Active Compounds of Nigella sativa in COVID-19: A Narrative Review. H U; S M; A A; Pk M; R K; R D; D S; Aa M; Panda PK Recent Adv Antiinfect Drug Discov; 2023 Feb; ():. PubMed ID: 36815641 [TBL] [Abstract][Full Text] [Related]
7. Nigelladine A among Selected Compounds from Miraz MMH; Ullah MA; Nayem AA; Chakrobortty B; Deb S; Laskar A; Tithi NU; Saha N; Chowdhury AR; Alam KMK; Wahed TB; Khursheed Alam M; Kundu SK Int J Clin Pract; 2023; 2023():9917306. PubMed ID: 36861057 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Inhibitors from Nigella Sativa. Baig A; Srinivasan H Appl Biochem Biotechnol; 2022 Mar; 194(3):1051-1090. PubMed ID: 35102539 [TBL] [Abstract][Full Text] [Related]
9. Imran M; Khan SA; Abida ; Alshammari MK; Alkhaldi SM; Alshammari FN; Kamal M; Alam O; Asdaq SMB; Alzahrani AK; Jomah S Molecules; 2022 Apr; 27(9):. PubMed ID: 35566101 [TBL] [Abstract][Full Text] [Related]
10. In Silico Studies on Zinc Oxide Based Nanostructured Oil Carriers with Seed Extracts of Hendi AA; Virk P; Awad MA; Elobeid M; Ortashi KMO; Alanazi MM; Alkallas FH; Almoneef MM; Abdou MA Molecules; 2022 Jul; 27(13):. PubMed ID: 35807545 [TBL] [Abstract][Full Text] [Related]
11. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study. Shahbazi B; Mafakher L; Teimoori-Toolabi L J Mol Model; 2022 Mar; 28(4):82. PubMed ID: 35249180 [TBL] [Abstract][Full Text] [Related]
12. Virtual screening of phytoconstituents from miracle herb Siddiqui S; Upadhyay S; Ahmad R; Gupta A; Srivastava A; Trivedi A; Husain I; Ahmad B; Ahamed M; Khan MA J Biomol Struct Dyn; 2022 Jun; 40(9):3928-3948. PubMed ID: 33289456 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study. Khan MT; Ali A; Wei X; Nadeem T; Muhammad S; Al-Sehemi AG; Wei D Braz J Biol; 2022; 84():e250667. PubMed ID: 35475989 [TBL] [Abstract][Full Text] [Related]
14. Active-site molecular docking of nigellidine with nucleocapsid-NSP2-MPro of COVID-19 and to human IL1R-IL6R and strong antioxidant role of Maiti S; Banerjee A; Nazmeen A; Kanwar M; Das S J Drug Target; 2022 Jun; 30(5):511-521. PubMed ID: 32875925 [TBL] [Abstract][Full Text] [Related]
15. Antiviral Activity of Cinchona officinalis, a Homeopathic Medicine, against COVID-19. Arumugam S; Vadivel K; Dhaked DK; Prasanna VS; Yellurkar ML; Das P; Manoharan R; Thomas AJ; Singh L; Singh S; Velayutham R Homeopathy; 2024 Feb; 113(1):16-24. PubMed ID: 37673083 [TBL] [Abstract][Full Text] [Related]
16. In vitro potential antiviral SARS-CoV-19- activity of natural product thymohydroquinone and dithymoquinone from Nigella sativa. Esharkawy ER; Almalki F; Hadda TB Bioorg Chem; 2022 Mar; 120():105587. PubMed ID: 35026560 [TBL] [Abstract][Full Text] [Related]
17. Plant derived active compounds as potential anti SARS-CoV-2 agents: an Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; BrĂ¡s NF; Jha HC J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565 [TBL] [Abstract][Full Text] [Related]
18. Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Mir SA; Firoz A; Alaidarous M; Alshehri B; Bin Dukhyil AA; Banawas S; Alsagaby SA; Alturaiki W; Bhat GA; Kashoo F; Abdel-Hadi AM Saudi J Biol Sci; 2022 Jan; 29(1):394-401. PubMed ID: 34518755 [TBL] [Abstract][Full Text] [Related]
19. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2. Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054 [TBL] [Abstract][Full Text] [Related]
20. Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies. Ali AM; Kunugi H Molecules; 2021 Feb; 26(5):. PubMed ID: 33669054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]